Lincoln Pharmaceuticals Share Price
₹812.10 -1.45 (-0.18%)
22 Dec, 2024 21:39
Start SIP in LINCOLN
Start SIPPerformance
- Low
- ₹791
- High
- ₹839
- 52 Week Low
- ₹535
- 52 Week High
- ₹980
- Open Price₹820
- Previous Close₹814
- Volume115,971
Investment Returns
- Over 1 Month + 31.58%
- Over 3 Month + 11.41%
- Over 6 Month + 31.58%
- Over 1 Year + 32.61%
Smart Investing Starts Here Start SIP with Lincoln Pharmaceuticals for Steady Growth!
Lincoln Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 16.8
- PEG Ratio
- 0.9
- Market Cap Cr
- 1,627
- P/B Ratio
- 2.7
- Average True Range
- 45.46
- EPS
- 48.25
- Dividend Yield
- 0.2
- MACD Signal
- 59.67
- RSI
- 51.41
- MFI
- 87.74
Lincoln Pharmaceuticals Financials
Lincoln Pharmaceuticals Technicals
EMA & SMA
Current Price
₹812.10
-1.45
(-0.18%)
- Bullish Moving Average 9
- Bearish Moving Average 7
- 20 Day
- ₹826.86
- 50 Day
- ₹758.82
- 100 Day
- ₹717.78
- 200 Day
- ₹672.93
Resistance and Support
814.12
- R3 885.48
- R2 862.37
- R1 837.23
- S1 788.98
- S2 765.87
- S3 740.73
Lincoln Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-14 | Quarterly Results | |
2024-08-08 | Quarterly Results | |
2024-05-16 | Audited Results & Final Dividend | |
2024-02-08 | Quarterly Results | |
2023-11-02 | Quarterly Results |
Lincoln Pharmaceuticals F&O
About Lincoln Pharmaceuticals
- NSE Symbol
- LINCOLN
- BSE Symbol
- 531633
- Managing Director
- Mr. Mahendra G Patel
- ISIN
- INE405C01035
Similar Stocks to Lincoln Pharmaceuticals
Lincoln Pharmaceuticals FAQs
Lincoln Pharmaceuticals share price is ₹812 As on 22 December, 2024 | 21:25
The Market Cap of Lincoln Pharmaceuticals is ₹1626.6 Cr As on 22 December, 2024 | 21:25
The P/E ratio of Lincoln Pharmaceuticals is 16.8 As on 22 December, 2024 | 21:25
The PB ratio of Lincoln Pharmaceuticals is 2.7 As on 22 December, 2024 | 21:25
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.